Cardiovascular Clinical Trials Market Size

Cardiovascular Clinical Trials Market size was over USD 5 Billion in 2023 and is anticipated to exceed USD 11.7 Billion by the end of 2036, witnessing over 6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of cardiovascular clinical trials is estimated at USD 6 Billion.

The growth of the market is prompted by the rising incidence of cardiac disorders like cardiac arrest, stoke, and coronary artery diseases. According to the World Heart Federation, cardiovascular diseases are ranked among the top diseases causing deaths and the global estimated deaths from cardiovascular diseases in the year 2021 were approximately 205 million. Besides, the enhancement in related government and industrial funding, along with the rising need to achieve greater cost avoidance in Phase III trials, are also driving market growth.